Exploring ctDNA-Guided Management in Melanoma
Watch Video
Signatera Webinars
-
-
Advancing Testicular Cancer Care with Personalized ctDNA Testing
Watch Video
-
Signatera Genome: Unlocking the next level of ultrasensitive MRD detection with Phased Variant technology
Watch Video
-
Partnering in Survivorship: The Oncology-OB/GYN connection in breast cancer surveillance
Watch Video
-
Signatera MRD Testing for NSCLC Patient Management
Watch Video
-
Personalized ctDNA testing in Urothelial Cancer
Watch Video
-
Signatera™ MRD Testing for Head and Neck Cancer
Watch Video
-
New data. Better insight. The future of precision breast cancer management
Watch Video
-
An MRD-guided approach to advancing treatment strategies in gynecologic cancer
Watch Video
-
Shaping the future of skin cancer: Tumor-informed ctDNA-guided interventions
Watch Video
-
From Detection to Decision-Making: Utility of Signatera in Complex GI & Hepatobiliary Malignancies
Watch Video
-
Integrating ctDNA and utDNA Across the Bladder Cancer Continuum
Watch Video
-
From Detection to Direction: Signatera MRD testing and its impact in CRC
Watch Video
-
Building the Evidence for ctDNA as a Surrogate Endpoint in Oncology Drug Development
Watch Video
-
Optimizing Breast Cancer Surveillance: A team approach with MRD testing
Watch Video
-
Leadership at Diagnosis: Quarterbacking the Path to Precision Care
Watch Video
-
Target, Track, Treat: Optimizing GI Cancer Management with Molecular Residual Disease Testing
Watch Video
-
New data from ASCO 2025 & clinical performance of Natera’s ultra-sensitive MRD platform
Watch Video
-
ctDNA monitoring with Signatera: An overview for transplant providers
Watch Video
-
Tiny Traces, Big Impact: Changing the Paradigm in Breast Cancer Management with MRD Testing
Watch Video
-
Loading More...
